A newly discovered enzyme called LysMD30 combined with the antibiotic colistin killed Vibrio bacteria 75% more efficiently than colistin alone, reducing the required antibiotic dose from 16-32 to 4-8 micrograms per milliliter in laboratory testing. According to Gram Research analysis of this 2026 study, the combination eliminated 99.9% of bacteria and biofilms within one hour, showing promise as an eco-friendly seafood safety solution, though human safety testing is still needed before real-world use.
Scientists discovered a new enzyme called LysMD30 that works powerfully with an existing antibiotic to kill dangerous Vibrio bacteria found in seafood. According to Gram Research analysis, this combination reduced the amount of antibiotic needed by 75% while completely eliminating bacterial colonies in just one hour. The enzyme comes from viruses that naturally attack these bacteria, making it a promising eco-friendly solution for keeping seafood safe during processing and storage. This breakthrough could help protect both food safety and aquaculture industries from increasingly antibiotic-resistant bacteria.
Key Statistics
A 2026 research study published in Applied and Environmental Microbiology found that combining the enzyme LysMD30 with colistin antibiotic reduced the required antibiotic dose by 75% across three Vibrio species, dropping from 16-32 micrograms per milliliter to 4-8 micrograms per milliliter.
Laboratory testing showed that the LysMD30 enzyme-antibiotic combination killed 99.9% of Vibrio bacteria and eliminated biofilms on food-contact surfaces within one hour, compared to much slower results with antibiotic treatment alone.
The enzyme LysMD30 maintained 36.96% activity when heated to 85°C and retained over 90% activity across pH levels of 5.0-8.0, suggesting it could survive food processing conditions like heating and salting without losing effectiveness.
In a live infection model, the LysMD30 and colistin combination provided 100% protection against lethal Vibrio infection while demonstrating excellent safety with no signs of toxicity to the host organism.
The Quick Take
- What they studied: Whether a newly discovered enzyme called LysMD30 could work together with an antibiotic drug to kill Vibrio bacteria that contaminate seafood
- Who participated: Laboratory research using 163 different Vibrio viruses and three species of harmful Vibrio bacteria, plus testing in a live infection model using insect larvae
- Key finding: The enzyme-antibiotic combination reduced the required antibiotic dose by 75% (from 16-32 to 4-8 micrograms per milliliter) and killed 99.9% of bacteria and biofilms within one hour
- What it means for you: This could lead to safer seafood with lower antibiotic use, reducing both foodborne illness risk and antibiotic resistance. However, this is early-stage research that still needs human safety testing before real-world use
The Research Details
Researchers searched through genetic material from 163 viruses that naturally infect Vibrio bacteria, looking for genes that code for bacteria-killing enzymes. They found 168 candidate genes and selected one called LysMD30 to study in detail. They grew this enzyme in a special yeast system and then tested how well it worked alone and combined with colistin, an antibiotic used against resistant bacteria.
The team tested the enzyme-antibiotic combination against three types of harmful Vibrio bacteria in laboratory dishes. They measured how quickly the bacteria died, how well the combination destroyed sticky bacterial films (biofilms) on food-contact surfaces, and whether the bacteria could develop resistance over time. They also tested the enzyme’s stability at different temperatures, pH levels, and salt concentrations to see if it would survive food processing conditions.
Finally, they used a live infection model with insect larvae to confirm the combination was safe and effective in a living system before considering it for food applications.
This research approach is important because it uses nature’s own bacteria-fighting tools rather than creating entirely new synthetic drugs. By studying viruses that naturally attack Vibrio bacteria, scientists can discover enzymes that are already optimized by evolution. Testing the enzyme with existing antibiotics is practical because it could be implemented quickly in food safety systems without waiting for completely new drugs to be developed and approved.
This is original research published in a peer-reviewed scientific journal (Applied and Environmental Microbiology), which means other experts reviewed it before publication. The study used multiple testing methods (laboratory cultures, biofilm testing, and live animal models) to confirm results from different angles. The researchers tested three different Vibrio species to show the findings aren’t limited to just one type of bacteria. However, this is laboratory research that hasn’t yet been tested in real food processing environments or in humans, so results may differ in real-world conditions.
What the Results Show
The enzyme LysMD30 alone couldn’t kill bacteria effectively, but when combined with colistin antibiotic, it became extremely powerful. The combination reduced the amount of antibiotic needed by 75%, dropping the effective dose from 16-32 micrograms per milliliter down to just 4-8 micrograms per milliliter across all three Vibrio species tested.
The killing speed was remarkably fast. Within just 5 minutes of exposure, bacteria began breaking apart and dying. By 20 minutes, most of the bacterial population was eliminated. This rapid action is important because it means less time for bacteria to develop resistance or spread contamination.
The combination was especially effective against biofilms—the sticky, protective layers bacteria form on surfaces like food-processing equipment and stainless steel. Within one hour, the enzyme-antibiotic combo reduced viable bacteria in these biofilms by more than 99.9%, essentially sterilizing the surfaces. This is significant because biofilms are notoriously difficult to clean and are a major source of food contamination.
The enzyme itself proved remarkably stable under harsh conditions. It retained about 37% of its activity even when heated to 85°C (185°F), maintained over 90% activity across a wide pH range (5.0-8.0), and kept more than 60% activity in high-salt conditions (800 millimolar sodium chloride). These properties suggest it could survive food processing methods like heating and salting without losing effectiveness.
When bacteria were exposed to the combination repeatedly over many generations, they developed resistance much more slowly than when exposed to colistin alone. This resistance-delaying effect is crucial because it extends the useful lifespan of the treatment before bacteria adapt to it.
In the live infection model using insect larvae, the enzyme-antibiotic combination provided 100% protection against lethal Vibrio infection while showing no signs of toxicity or harm to the host organism, suggesting excellent safety for potential use.
This is the first time researchers have identified and characterized an enzyme (endolysin) from Vibrio-attacking viruses that works synergistically with antibiotics. Previous research showed that enzymes from other bacterial viruses could kill bacteria, but this study demonstrates a new level of effectiveness through the enzyme-antibiotic combination. The 75% reduction in required antibiotic dose is substantially better than most previous enzyme-antibiotic combinations reported in scientific literature. The rapid biofilm elimination (within 1 hour) also exceeds what’s typically achieved with antibiotics alone, which often struggle with biofilm penetration.
This research was conducted entirely in laboratory settings and controlled animal models, not in actual food processing environments or human bodies. The enzyme was tested against only three Vibrio species, so effectiveness against other bacteria remains unknown. The study didn’t test whether the enzyme could be produced at large, cost-effective scales needed for commercial food processing. Long-term stability during actual food storage and processing hasn’t been evaluated. The insect larvae model, while useful for safety screening, doesn’t perfectly replicate how the treatment would work in human food consumption. Finally, regulatory approval for food use would require extensive additional testing before this could be implemented in real-world seafood processing.
The Bottom Line
Based on this research, the enzyme-antibiotic combination shows strong promise as a future food safety tool (high confidence in laboratory effectiveness). However, it’s not ready for consumer use yet. Researchers should next test it in actual seafood processing conditions and conduct human safety studies. For food industry professionals: monitor this research as a potential solution for biofilm control on equipment. For consumers: this doesn’t change current food safety practices, but represents a promising development for future seafood safety improvements.
Seafood processors and aquaculture operations should follow this research closely as a potential solution for reducing Vibrio contamination and antibiotic use. Food safety regulators should consider supporting further development. Consumers concerned about antibiotic resistance in food should view this as a positive development, though it won’t affect food safety practices for several years. People with shellfish allergies or those avoiding colistin should note this combines with that antibiotic, so it wouldn’t be suitable for them. This research is less relevant for people who don’t consume seafood or those in regions where Vibrio contamination isn’t a concern.
If development proceeds smoothly, this technology could potentially be tested in pilot food processing facilities within 2-3 years. Regulatory approval for commercial use would likely take 5-10 years minimum. Real-world availability in seafood processing would probably occur 7-15 years from now, assuming successful safety and efficacy testing. Consumers wouldn’t see direct benefits until widespread industry adoption occurs, which would take even longer.
Frequently Asked Questions
Can this new enzyme treatment make seafood safer from Vibrio bacteria?
Laboratory research shows the enzyme LysMD30 combined with colistin antibiotic eliminated 99.9% of Vibrio bacteria and biofilms within one hour. However, this is early-stage research that still needs testing in actual food processing and human safety studies before it can be used commercially.
How much less antibiotic would be needed with this enzyme treatment?
The enzyme-antibiotic combination reduced the required colistin dose by 75%, dropping from 16-32 micrograms per milliliter to just 4-8 micrograms per milliliter. This lower antibiotic requirement could help reduce antibiotic resistance development.
Would this enzyme survive food processing like cooking and salting?
Laboratory testing showed LysMD30 retained 37% activity when heated to 85°C and over 90% activity in acidic to neutral conditions and high-salt environments, suggesting it could survive some food processing methods, though real-world testing is needed.
When will this enzyme treatment be available for seafood?
This is laboratory research from 2026 that still requires extensive safety testing and regulatory approval. Commercial availability in seafood processing would likely take 7-15 years minimum, assuming successful development and approval.
Is this enzyme treatment safe for people to eat?
Testing in insect larvae showed 100% safety with no toxicity, but human safety studies haven’t been conducted yet. Regulatory agencies would require extensive additional testing before approving it for food use.
Want to Apply This Research?
- Users interested in food safety could track seafood consumption frequency and any gastrointestinal symptoms within 48 hours of eating shellfish, creating a personal baseline for foodborne illness risk. This data becomes more valuable once new food safety technologies like this enzyme treatment are implemented.
- Set reminders to check seafood freshness dates and storage temperatures, since proper handling remains the primary defense against Vibrio contamination until new technologies are available. Users could log seafood purchases and storage conditions to identify personal risk patterns.
- Create a long-term food safety journal tracking any gastrointestinal symptoms correlated with seafood consumption. Once enzyme-treated seafood becomes available (if labeled), users could compare symptom rates before and after, contributing to real-world safety data.
This research describes laboratory findings about a novel enzyme treatment that is not yet approved for use in food processing or human consumption. The results are promising but represent early-stage research. This information is for educational purposes only and should not be used to make decisions about food safety practices. Consult with food safety professionals and regulatory agencies for current approved methods to prevent Vibrio contamination. If you experience symptoms of foodborne illness (severe diarrhea, vomiting, abdominal pain), seek immediate medical attention. Always follow current food safety guidelines for seafood storage, handling, and preparation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.